Bifidobacterium lactis 用于 免疫衰老
B 证据 至少一项随机试验支持这一结论,结果基本一致。Meta-analysis demonstrates short-term Bifidobacterium lactis supplementation may enhance NK cell activity and polymorphonuclear phagocytic capacity in healthy elderly adults. Supports balanced Th1/Th2 immune response in aging populations.
结论
Meta-analysis demonstrates short-term Bifidobacterium lactis supplementation may enhance NK cell activity and polymorphonuclear phagocytic capacity in healthy elderly adults. Supports balanced Th1/Th2 immune response in aging populations.
Key Study Findings
研究人群: None
研究人群: Elderly subjects (63-84 years)
Key Statistics
5
研究数量
300
受试者
Positive
等级
Referenced Papers
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
常用剂量
- general:
- 1-10 billion CFU/day
上限: No established UL
研究中使用的剂量
| 剂量 | 持续时间 | 效果 | N |
|---|---|---|---|
| 12 g | -- | Mixed | -- |
| L. rhamnosus HN001 or B. lactis HN019 | 3 weeks | Positive | 27 |
最佳服用时间: With meals or on empty stomach; consistent daily use
Safety & Side Effects
已报告的副作用
- ⚠ Mild bloating and gas (usually transient)
- ⚠ Generally very well tolerated
已知相互作用
- ● Antibiotics (may reduce probiotic effectiveness; space doses 2+ hours apart)
可耐受最高摄入量: No established UL
在开始服用任何补充剂之前,请务必咨询您的医疗保健提供者。
Frequently Asked Questions
Does Bifidobacterium lactis help with 免疫衰老?
How much Bifidobacterium lactis should I take for 免疫衰老?
Are there side effects of Bifidobacterium lactis?
How strong is the evidence for Bifidobacterium lactis and 免疫衰老?
Related Evidence
References
- [1] Da-Yong Zhang et al.. J Immunol Res. 2019. Bifidobacterium lactis BB-12 Attenuates Macrophage Aging Induced by D-Galactose and Promotes M2 Macrophage Polarization. doi:10.1155/2019/4657928 PubMed
- [2] H S Gill et al.. J Clin Immunol. 2001. Dietary probiotic supplementation enhances natural killer cell activity in the elderly: an investigation of age-related immunological changes. doi:10.1023/a:1010979225018 PubMed
FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。